Literature DB >> 545720

Dedifferentiated variants of a rat hepatoma: analysis by cell hybridization.

J Deschatrette, E E Moore, M Dubois, D Cassio, M C Weiss.   

Abstract

Two independent dedifferentiated variants, H5 and FaoflC2, derived from the Reuber H35 hepatoma, produce trans-acting diffusible substances(s) that extinguish the expression of liver-specific proteins when hybridized with a well-differentiated cell line of the same origin (Fao and Fu5-5, respectively). H5 x Fao hybrids show total and stable extinction of four liver functions and clonal variability in the expression of three others. FaoflC2 x Fu5-5 hybrids are initially flat (like FaoflC2 cells), and die in glucose-free medium where survival requires expression of hepatic gluconeogenic enzymes, but then evolve to hepatoma-like and finally round morphology; these latter cells express all liver functions analyzed including the gluconeogenic enzymes. Two exceptional clones that remained flat long enough for complete analysis showed extinction of all hepatic functions not expressed by FaoflC2 cells. We conclude that this transitory extinction reflects the action and then loss of extinguishing factor(s) contributed by FaoflC2. When crossed with BW1-J mouse hepatoma cells. FaoflC2 causes stable extinction of mouse aldolase B. We propose that production of extinguishing factor(s) is the rule for dedifferentiated variants.

Entities:  

Mesh:

Year:  1979        PMID: 545720     DOI: 10.1007/BF01542636

Source DB:  PubMed          Journal:  Somatic Cell Genet        ISSN: 0098-0366


  26 in total

1.  Liver-enriched transcription factors uncoupled from expression of hepatic functions in hepatoma cell lines.

Authors:  D Chaya; C Fougère-Deschatrette; M C Weiss
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

2.  An enhancer element in the house-keeping promoter for acetyl-CoA carboxylase gene.

Authors:  X C Luo; K H Kim
Journal:  Nucleic Acids Res       Date:  1990-06-11       Impact factor: 16.971

3.  Extinction of alpha-fetoprotein gene expression in somatic cell hybrids involves cis-acting DNA elements.

Authors:  S G Widen; J Papaconstantinou
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

4.  Tyrosine phosphorylation of the insulin receptor is not required for receptor internalization: studies in 2,4-dinitrophenol-treated cells.

Authors:  J M Backer; C R Kahn; M F White
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

5.  Determinants of rat albumin promoter tissue specificity analyzed by an improved transient expression system.

Authors:  J M Heard; P Herbomel; M O Ott; A Mottura-Rollier; M Weiss; M Yaniv
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

6.  Two systems in vitro that show insulin-stimulated serine kinase activity towards the insulin receptor.

Authors:  D M Smith; M J King; G J Sale
Journal:  Biochem J       Date:  1988-03-01       Impact factor: 3.857

7.  Expression from the tyrosine aminotransferase promoter (nt -350 to +1) is liver-specific and dependent on the binding of both liver-enriched and ubiquitous trans-acting factors.

Authors:  G Schweizer-Groyer; A Groyer; F Cadepond; T Grange; E E Baulieu; R Pictet
Journal:  Nucleic Acids Res       Date:  1994-05-11       Impact factor: 16.971

8.  Molecular cloning of cDNA for rat argininosuccinate lyase and its expression in rat hepatoma cell lines.

Authors:  M A Lambert; L R Simard; P N Ray; R R McInnes
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

9.  Monoclonal antibody-based, selective isolation of DNA fragments containing an alkylated base to be quantified in defined gene sequences.

Authors:  K Hochleitner; J Thomale; M F Rajewsky
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

10.  Correlated expression of T cell growth factor dependence, sensitivity to Vicia villosa lectin, and cytolytic activity in hybrids between cytolytic T cells and T lymphomas.

Authors:  A Conzelmann; A Silva; M Cianfriglia; C Tougne; R P Sekaly; M Nabholz
Journal:  J Exp Med       Date:  1982-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.